Altimmune, Inc. financial data

Symbol
ALT on Nasdaq
Location
910 Clopper Road, Suite 201 S, Gaithersburg, MD
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.64K % +15.1%
Debt-to-equity 13.3 % +29%
Return On Equity -62.6 % -3.5%
Return On Assets -55.3 % -0.78%
Operating Margin -472K % -1659%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 88.3M shares +24.2%
Common Stock, Shares, Outstanding 85.1M shares +19.7%
Entity Public Float 469M USD +154%
Common Stock, Value, Issued 9K USD +28.6%
Weighted Average Number of Shares Outstanding, Basic 81.5M shares +14.9%
Weighted Average Number of Shares Outstanding, Diluted 81.5M shares +14.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 20K USD -95.1%
Research and Development Expense 72.6M USD -6.79%
General and Administrative Expense 21.7M USD +10.1%
Operating Income (Loss) -94.4M USD +14%
Nonoperating Income (Expense) 5.94M USD -28.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -22.1M USD +10.1%
Income Tax Expense (Benefit) -681K USD
Net Income (Loss) Attributable to Parent -87.7M USD +13.4%
Earnings Per Share, Basic -1 USD/shares +27.6%
Earnings Per Share, Diluted -1 USD/shares +27.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 183M USD +221%
Assets, Current 188M USD +10.1%
Property, Plant and Equipment, Net 364K USD -24.6%
Operating Lease, Right-of-Use Asset 1.64M USD +352%
Intangible Assets, Net (Excluding Goodwill) 0 USD
Other Assets, Noncurrent 1.56M USD -6.74%
Assets 190M USD +9.81%
Accounts Payable, Current 851K USD -68.3%
Employee-related Liabilities, Current 1.83M USD -9.91%
Liabilities, Current 9.22M USD -39.2%
Operating Lease, Liability, Noncurrent 1.28M USD -15.8%
Other Liabilities, Noncurrent 5.43M USD +17419%
Liabilities 29M USD +39.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -5.04M USD +2.95%
Retained Earnings (Accumulated Deficit) -603M USD -17%
Stockholders' Equity Attributable to Parent 161M USD +5.79%
Liabilities and Equity 190M USD +9.81%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -16.8M USD -2.95%
Net Cash Provided by (Used in) Financing Activities 34.1M USD
Net Cash Provided by (Used in) Investing Activities -5.1M USD +87.1%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 85.1M shares +19.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12.2M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 183M USD +220%
Deferred Tax Assets, Valuation Allowance 106M USD +28.3%
Deferred Tax Assets, Gross 107M USD +28.7%
Operating Lease, Liability 1.68M USD +151%
Depreciation 29K USD -72.9%
Payments to Acquire Property, Plant, and Equipment 51K USD +467%
Lessee, Operating Lease, Liability, to be Paid 2.13M USD +204%
Property, Plant and Equipment, Gross 2.63M USD 0%
Operating Lease, Liability, Current 239K USD -30.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 376K USD +114%
Lessee, Operating Lease, Liability, to be Paid, Year One 422K USD -19.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +27.8%
Deferred Income Tax Expense (Benefit) -681K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 450K USD +1352%
Lessee, Operating Lease, Liability, to be Paid, Year Three 387K USD
Deferred Tax Assets, Operating Loss Carryforwards 64.8M USD +19.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 700K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 398K USD
Operating Lease, Payments 100K USD 0%
Additional Paid in Capital 770M USD +14.3%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 451K USD +360%
Share-based Payment Arrangement, Expense 14M USD +6.64%
Interest Expense 34K USD -50%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%